Litcius/Paper detail

Lecanemab: First Approval

Sheridan M. Hoy

2023Drugs136 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDementiaClinical trialDiseaseCognitive impairmentDrug developmentIntensive care medicinePharmacologyInternal medicineDrugAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesTryptophan and brain disorders
Lecanemab: First Approval | Litcius